External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ELCC 2022
Roche and Genentech at

ELCC 2022

March 30 - April 02
Prague, Czech Republic / Virtual (Hybrid)
iaslc.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Highlights
Coming soon
03:55 PM
Duration 10mins Virtual
Atezolizumab▼ (atezo) vs best supportive care (BSC) in stage II-IIIA NSCLC with high PD-L1 expression: sub-analysis from the pivotal phase III IMpower010 study
Felip E, Altorki N, Zhou C, Vallieres E, Vynnychenko IO, Akopov A, Martinez-Marti A, Chella A, Bondarenko I, Ursol G, Levchenko E, Kislov N, Liersch R, Belleli R, McNally V, Bennett E, Gitlitz BJ, Wakelee HA
Oncology | Lung Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.